In response to the recent @NYTimes editorial on cannabis and as a committee member on the @theNASEM #cannabis and #cannabinoids report we did NOT conclude that cannabis causes schizophrenia.
What Advocates of Legalizing Pot Don’t Want You to Know
Ziva Cooper
581 posts
Ziva Cooper
@zivacooper
Pharmacologist focused on effects of cannabis / cannabinoids. Director of UCLA's Center for Cannabis and Cannabinoids @UCLACannabis
- Do women and men respond differently to cannabis? What factors contribute to these differences? The @UCLA Cannabis Research Initiative is going to find out! ucla.in/2O5sg3f @UCLASemelFriend
- #Cannabis decreases the opioid dose needed for pain relief. Our double-blind, placebo-controlled study now available online! nature.com/articles/s4138… @ICRS_Society
- Topical CBD now in Walgreens and CVS in select states. And we still need a 750 lb safe to store it in the lab.......Walgreens will sell CBD creams, patches and sprays in nearly 1,500 stores in select states. cnb.cx/2FEKMN6
- Replying to @zivacooperWe found 1) an #association between cannabis use and schizophrenia and 2) an #association between cannabis use and IMPROVED cognitive outcomes in individuals with psychotic disorders (not mentioned in the editorial).
- Replying to @zivacooperWe also now know that under placebo-controlled conditions, #cannabidiol (#CBD) improves outcomes in patients with schizophrenia when given as an adjunct med, showing that cannabinoids (not necessarily cannabis) improve symptoms. ncbi.nlm.nih.gov/pubmed/29241357
- The @UCLA Cannabis Research Initiative will be base camp for interdisciplinary cannabis and cannabinoid research from molecular pharmacology to public policy. Research Director Q&A:The newly named director of UCLA Cannabis Research Initiative wants to study societal impacts of cannabis. Here's a Q&A: ucla.in/2Gil7tD
newsroom.ucla.eduUCLA researcher aims to study societal impacts of cannabisZiva Cooper, of the UCLA Cannabis Research Institute, will direct interdisciplinary teams of scholars with specialties in medicine, public health, policy, science and law. - Replying to @zivacooperDownload the @theNASEM report to learn more about the over 100 #associations between #cannabis, #cannabinoids, and #health outcomes. nationalacademies.org/hmd/Reports/20…
- Big news... and it only took 5 years to get here! Hope it will take less than 5 years for this decision to have a + impact on research... DEA Finally Ready To End Federal Marijuana Research Monopoly, Agency Notifies Grower Applicants | Marijuana Moment
- Replying to @zivacooperSince the report, we now know that genetic risk for schizophrenia predicts cannabis use, shedding some light on the potential direction of the association between cannabis use and schizophrenia.
- Huge congratulations to @canna_brain on receiving the @ICRS_Society Young Investigators Award 👏🏼 👏🏼 👏🏼! Looking forward to his talk on cannabinoids, stress, and anxiety #ICRS19
- Dose and cannabis experience are really important variables to consider when assessing CBD's effects on THC! Lots of interesting findings in this new pub: A RCT of vaporized #THC and #CBD alone and in combination. ncbi.nlm.nih.gov/pubmed/30661105
- Interested in cannabis / cannabinoid research? We're hiring postdoctoral fellows to join the UCLA Cannabis Research Initiative team. Please spread the word! @ICRS_Society @ccictweeter @CPDD19 uclahealth.org/cannabis/
- Very excited to be joining the @npp_journal team as Associate Editor - many thanks for the warm welcome from @ACNPorg and the twitter community!Please join us in welcoming Dr. Ziva Cooper @zivacooper to @npp_journal leadership as an Associate Editor beginning this September. Ziva is the Director of the Center for Cannabis and Cannabinoids at the University of California at Los Angeles (UCLA),
